189 filings
Page 7 of 10
6-K
9vcy1f
6 Jul 18
Current report (foreign)
4:37pm
EFFECT
duupp21h6 vf
8 Jun 18
Notice of effectiveness
12:00am
6-K
cs0qhasq
7 Jun 18
Invitation to the Ordinary Shareholders' Meeting
4:06pm
CORRESP
v2n0si8j6kr 0m02em0
6 Jun 18
Correspondence with SEC
12:00am
F-3/A
ipe9uuiw
25 May 18
Shelf registration (foreign) (amended)
6:31am
CORRESP
dexyjo3k
25 May 18
Correspondence with SEC
12:00am
UPLOAD
xfz11
17 May 18
Letter from SEC
12:00am
F-3
f1e74l7vnn
4 May 18
Shelf registration (foreign)
5:25pm
6-K
jdn3i1afy
2 May 18
Current report (foreign)
6:00am
6-K
cdaff42jjkltt
27 Apr 18
Current report (foreign)
4:43pm
6-K
laywe1 ddfgz
26 Mar 18
Current report (foreign)
12:00am
6-K
omklnqd2kk0my
22 Mar 18
Invitation to the Extraordinary Shareholders' Meeting
12:00am
6-K
oraog
20 Mar 18
AC Immune reports full-year 2017 financial results – successful first year as a public company
12:00am
6-K
iwvg2sb1v 1m5n7n
13 Nov 17
Current report (foreign)
12:00am
6-K
iyiab 7w3vr0ude1i7a3
2 Nov 17
AC Immune to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer’s Disease
12:00am
6-K
co3yz
9 Aug 17
Current report (foreign)
12:00am
6-K
gugcx2qdyj8zc
28 Jun 17
Current report (foreign)
12:00am
6-K
c81d1u9k
1 Jun 17
Invitation to the Ordinary Shareholders' Meeting
12:00am
6-K
9486ekaotb p03q
11 May 17
Current report (foreign)
12:00am